Tag Archives: U.S. Securities and Exchange Commission

Canadian biopharma Zymeworks files for $75 million IPO; name may sound funky but gameplan dead serious

Biopharmaceutical company Zymeworks Inc. (Vancouver BC) on Monday (April 3, 2107) said it has filed with the US Securities and Exchange Commission for an initial public offering. The company, which… Read more »

Walgreens cuts offer for Rite Aid, casting doubt on merger; analysts say deal still alive

The News: Walgreens Boots Alliance (Deerfield IL) on Monday (January 30, 2017) entered into a new agreement with Rite Aid (Camp Hill PA) to buy the drugstore chain for at least $2 less per share… Read more »

Mallinckrodt will pay $100 million to settle drug antitrust (price-gouging) charges; why competition, not fines, is the only antidote

The News: Irish drugmaker Mallinckrodt PLC (Dublin) and a US subsidiary will pay $100 million and agree to other conditions to settle government antitrust allegations they unlawfully prevented competition for… Read more »

Valeant divests assets worth $2.1 billion to ease debt load; finally a smart move, but too little, too late?

Valeant Pharmaceuticals International Inc. (Laval Quebec) is selling its Dendreon cancer treatment business and three skincare brands for $2.12 billion as the troubled Canadian drugmaker looks to reduce more than… Read more »

Democrats demand probe into stock trading of Trump’s HHS nominee; GOP’s righteous indignation misplaced, puzzling

Senate Democrats on Thursday (January 5, 2016) demanded an ethics probe into Tom Price, President-elect Donald Trump’s pick for US health secretary, following a report that the fierce Obamacare critic… Read more »

Alexion Suddenly Ousts CEO, CFO; what’s really going on?

Alexion Pharmaceuticals Inc. (New Haven CT), maker of one of the world’s most expensive medicines, announced on Monday (December 12, 2106) its CEO and CFO were departing amid an internal… Read more »

Mylan discloses two more government probes; posts 3Q loss as EpiPen Woes Persist

The maker of EpiPen emergency allergy injectors, under a microscope for repeatedly hiking the price of the life-saving device, revealed that it’s a target of two price-related probes by federal… Read more »

Theranos Pivots From Blood Tests to New Lab Product; Will “Phoenix” Effort Succeed?

Beleaguered startup Theranos Inc. (Palo Alto CA) will close its blood-testing labs and fire about 340 workers, shifting its focus to an experimental technology following months of run-ins with regulators and… Read more »

Glaxo Settles Bribery Charges with SEC for $20 Million; Cozy Relation of Pharma with Docs a Thing of the Past?

GlaxoSmithKline PLC (London) will pay $20 million to settle civil charges that it masked bribes to foreign officials in China by disguising them as legitimate travel, entertainment and marketing expenses,… Read more »

Mylan Agrees to $465 Million EpiPen Settlement with US; But the Matter is Far From Over

Mylan NV (Amsterdam) will pay the US government $465 million in a swift settlement over how the drugmaker charged Medicaid for its allergy shot EpiPen, according to Bloomberg News. The… Read more »